blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1578908

EP1578908 - HUMAN SCHIZOPHRENIA GENE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.04.2009
Database last updated on 14.09.2024
Most recent event   Tooltip24.04.2009Application deemed to be withdrawnpublished on 27.05.2009  [2009/22]
Applicant(s)For all designated states
Decode Genetics EHF.
Sturlugötu 8
101 Reykjavik / IS
[2005/39]
Inventor(s)01 / STEFANSSON, Hreinn
Krokamvri 30
IS-210 Gardabaer / IS
02 / STEINTHORSDOTTIR, Valgerdur
Silfurteigur 3
IS-105 Reykjavik / IS
03 / GULCHER, Jeffrey, R.
130 South Canal Street, 9M
Chicago, IL 60606 / US
04 / GURNEY, Mark
910 Rosewood Avenue, SE
East Grand Rapids, MI 49506 / US
05 / ANDRESSON, Thorkell
Asgardur 75
IS-108 Reykjavik / IS
 [2005/39]
Representative(s)Fridriksson, Einar Karl
Arnason Faktor
Intellectual Property Consulting
Gudridarstig 2-4
113 Reykjavik / IS
[N/P]
Former [2005/39]Fridriksson, Einar Karl
A&P Arnason ehf., Intellectual Property Group, Efstaleiti 5
103 Reykjavik / IS
Application number, filing date02775752.505.09.2002
[2005/39]
WO2002US28193
Priority number, dateUS2001094680705.09.2001         Original published format: US 946807
US2002010760426.03.2002         Original published format: US 107604
[2005/39]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03020911
Date:13.03.2003
Language:EN
[2003/11]
Type: A2 Application without search report 
No.:EP1578908
Date:28.09.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 13.03.2003 takes the place of the publication of the European patent application.
[2005/39]
Search report(s)International search report - published on:US04.05.2006
(Supplementary) European search report - dispatched on:EP20.11.2007
ClassificationIPC:A61K31/70, C12Q1/68
[2006/29]
CPC:
C07K14/4756 (EP,US); A01K67/0276 (EP,US); A61K38/179 (EP,US);
A61P25/18 (EP); C07K14/47 (EP,US); C12Q1/6883 (EP,US);
G01N33/6893 (EP,US); A01K2217/05 (EP,US); A01K2227/105 (EP,US);
A01K2267/0356 (EP,US); A61K38/00 (EP,US); C07K2319/00 (EP,US);
C12Q2600/156 (EP,US); G01N2500/04 (EP,US); G01N2800/2835 (EP,US);
G01N2800/302 (EP,US) (-)
Former IPC [2005/39]C12N1/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2005/39]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:MENSCHLICHES SCHIZOPHRENIEGEN[2005/39]
English:HUMAN SCHIZOPHRENIA GENE[2005/39]
French:GENE HUMAIN DE LA SCHIZOPHRENIE[2005/39]
Entry into regional phase02.04.2004National basic fee paid 
02.04.2004Search fee paid 
02.04.2004Designation fee(s) paid 
02.04.2004Examination fee paid 
Examination procedure02.04.2004Examination requested  [2005/39]
13.05.2008Despatch of a communication from the examining division (Time limit: M06)
25.11.2008Application deemed to be withdrawn, date of legal effect  [2009/22]
09.01.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/22]
Fees paidRenewal fee
14.09.2004Renewal fee patent year 03
21.09.2005Renewal fee patent year 04
27.09.2006Renewal fee patent year 05
26.09.2007Renewal fee patent year 06
25.09.2008Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9842362  (MILLENNIUM PHARM INC [US], et al) [A] 1-28,33-42 * abstract *;
 [X]WO9962955  (BIOMOLECULAR RESEARCH INST LIM [AU], et al) [X] 13-17 * the whole document *;
 [PX]WO0164877  (DECODE GENETICS EHF [IS], et al) [PX] 1-28,33-42 * the whole document *;
 [X]  - JESCHKE M ET AL, "TARGETED INHIBITION OF TUMOR-CELL GROWTH BY RECOMBINANT HEREGULIN- TOXIN FUSION PROTEINS", INTERNATIONAL JOURNAL OF CANCER, NEW YORK, NY, US, (19950303), vol. 60, no. 5, ISSN 0020-7136, pages 730 - 739, XP000571537 [X] 1,2,7,8,14,15 * abstract *

DOI:   http://dx.doi.org/10.1002/ijc.2910600527
 [X]  - TANG C K ET AL, "ErbB - 4 ribozymes abolish neuregulin-induced mitogenesis", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, (19980801), vol. 58, no. 15, ISSN 0008-5472, pages 3415 - 3422, XP002108381 [X] 1,2,7-9,14,15 * abstract *
 [X]  - AZEMAR MARC ET AL, "Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo", INTERNATIONAL JOURNAL OF CANCER, (20000415), vol. 86, no. 2, ISSN 0020-7136, pages 269 - 275, XP002445533 [X] 1,2,5,8,14,15 * abstract *

DOI:   http://dx.doi.org/10.1002/(SICI)1097-0215(20000415)86:2<269::AID-IJC18>3.0.CO;2-8
 [A]  - BUONANNO ANDRES ET AL, "Neuregulin and ErbB receptor signaling pathways in the nervous system.", CURRENT OPINION IN NEUROBIOLOGY, (200106), vol. 11, no. 3, ISSN 0959-4388, pages 287 - 296, XP002445534 [A] 1-28,33-42 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0959-4388(00)00210-5
 [T]  - STEFANSSON H ET AL, "Neuregulin 1 and susceptibility to schizophrenia", AMERICAN JOURNAL OF HUMAN GENETICS, AMERICAN SOCIETY OF HUMAN GENETICS, CHICAGO, IL, US, (20020723), vol. 71, ISSN 0002-9297, pages 877 - 892, XP002984389 [T] 1-28,33-42 * the whole document *

DOI:   http://dx.doi.org/10.1086/342734
International search[A]  - TALMAGE D A ET AL, "Multiple personalities of neuregulin gene family members.", J COMP NEUROL., (2004), vol. 472, pages 134 - 139, XP009053195

DOI:   http://dx.doi.org/10.1002/cne.20091
 [A]  - HARRISON P J ET AL, "Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.", MOL PSYCHIATRY., (2005), vol. 10, pages 40 - 68, XP009061024

DOI:   http://dx.doi.org/10.1038/sj.mp.4001558
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.